|Type||Journal Article - Archives of Iranian medicine|
|Title||The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study|
Background: Hepatitis B virus infection is a very common cause of chronic liver disease
worldwide. It is estimated that 3% of Iranians are chronically infected with hepatitis B virus. Current
population-based studies on both rural and urban prevalence of hepatitis B virus infection in Iran
are sparse with results that do not always agree. We performed this study to find the prevalence of
hepatitis B surface antigen, anti-hepatitis B core antibody, and associated factors in the general
population of three provinces of Iran.
Methods: We randomly selected 6,583 subjects from three provinces in Iran, namely Tehran,
Golestan, and Hormozgan. The subjects were aged between 18 and 65 years. Serum samples were
tested for hepatitis B surface antigen and anti-hepatitis B core antibody. Various risk factors were
recorded and multivariate analysis was performed.
Results: The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in
Iran was 2.6% and 16.4%, respectively. Predictors of hepatitis B surface antigen or anti-hepatitis B
core antibody in multivariate analysis included older age, not having high-school diploma, living in
a rural area, and liver disease in a family member. We did not find any significant differences
between males and females.
Conclusion: In spite of nationwide vaccination of newborns against hepatitis B virus since
1992, hepatitis B virus infection remains a very common cause of chronic liver disease in Iran
which should be dealt with for at least the next 30 – 50 years.
|»||Iran, Islamic Rep. - General Census of Population and Housing 2006|